title: Introduction: cardiovascular safety and triptans in the acute treatment of migraine.
authors.affiliation: Department of Neurology, Mayo Clinic Scottsdale, AZ 85259, USA.
authors.forename: David W
authors.initials: DW
authors.lastname: Dodick
mesh_terms: D000208:Acute Disease; D003327:Coronary Disease / Q000139:chemically induced; D019317:Evidence-Based Medicine; D006801:Humans; D008881:Migraine Disorders / Q000188:drug therapy*; D017202:Myocardial Ischemia / Q000139:chemically induced; D012307:Risk Factors; D017366:Serotonin Receptor Agonists / Q000009:adverse effects / Q000627:therapeutic use*; D014662:Vasoconstrictor Agents / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D017366:Serotonin Receptor Agonists; D014662:Vasoconstrictor Agents